hemo- (also haemo-, hem-, haem-, hemat-, haemat-) is a combining form derived from the Greek haima meaning “blood,” used at the beginning of medical terms to indicate a relationship to blood — its composition, movement, pathology, or the procedures performed on it. Unlike -emia, which is a suffix denoting a condition of the blood, hemo- is a prefix or stem that anchors the term to blood as its subject, with the clinical meaning then shaped by the following element (e.g., -rrhage = bursting forth → hemorrhage; -lysis = destruction → hemolysis; -stasis = stopping → hemostasis). The underlying structural role is purely compositional — hemo- carries no inherent pathological or physiological charge on its own; rather, it localizes the clinical concept to the blood compartment, the vascular space, or blood-derived tissue. It appears in both physiological terms (e.g., hematopoiesis — normal blood cell formation) and pathological terms (e.g., hemoptysis — coughing up blood; hematoma — a collection of clotted blood). In ICD-10-CM, hemo- terms are distributed across Chapter 3 (D50-D89, blood disorders), Chapter 10 (J04-J99, respiratory hemorrhage), Chapter 19 (S/T codes, traumatic hematomas), and procedural chapters of ICD-10-PCS. It is commonly confused with -emia, which is its suffix counterpart — the key distinction is positional and functional: hemo- builds the front of a term and identifies the subject; -emia closes the term and names the blood condition.
Greek haima (HY-mah), from Proto-Indo-European *seh₁i- (“to pour, let flow”)
“blood” — combining form used before consonants; the h is retained in Greek-origin forms and dropped in Latin-influenced spellings; British English retains haemo-, American English standardizes hemo-
”of blood,” “blood’s” — the genitive (possessive) combining form; used before vowel-initial suffixes (e.g., hemat-ology, hemat-oma) for phonological smoothness
-o-
Greek linking vowel
Connecting vowel — “of, pertaining to” — joins the root to the following element; present in hemo- but absent in hem- variants used before vowels
The combining form entered formal English medical vocabulary in the 1840s-1850s as hemo- and haemo- (combining form), borrowed from Greek haima (“blood”) — literally “blood.” The British variant haemo- (and haem-) preserves the aspirate and is standard in UK, Australian, and Canadian medical literature; hemo- is the American English standard per AMA style. The root haima (“blood”) connects hemo- to the entire hem- root family: hemoglobin (haima + globus → blood’s globular oxygen carrier), hemorrhage (haima + rhegnynai → bursting forth of blood), hematopoiesis (haima + poiesis → making of blood), and hemostasis (haima + -stasis → stopping of blood). The root haima is extraordinarily productive in medical terminology, appearing in: hemophilia, hematuria, hemolysis, hemothorax, hemodialysis, hemoptysis, and -emia (its suffix form).
🔀 ALIASES / ALTERNATE TERMS
hemat-(genitive combining form — used before vowel-initial suffixes; e.g., “hematology,” “hematoma,” “hematuria”; interchangeable with hemo- in many terms)
haemo- / haem-(British English standard variants — identical meaning; used in “haemorrhage,” “haemoglobin,” “haematology”; encountered in imported UK clinical literature and older references)
hemoglobin(the iron-containing oxygen-transport protein of red blood cells; the molecular subject of many hemo- disorders — e.g., hemoglobinopathy, sickle cell disease D57.x)
hematoma(a localized collection of blood outside vessels, typically clotted; coded by anatomic site — e.g., S09.90XA traumatic, M79.81 nontraumatic soft tissue; high frequency in surgical inpatient coding)
hematuria(blood in the urine — a cardinal urology sign; R31.0 gross hematuria, R31.1 benign essential microscopic, R31.21 asymptomatic microscopic; must be distinguished from underlying cause)
hemoptysis(coughing up blood from the respiratory tract; R04.2; distinct from hematemesis — vomiting blood — R10.11/ K92.0)
hematemesis(vomiting of blood — GI source; K92.0; clinically and anatomically distinct from hemoptysis; both begin with hemo- but differ entirely in site and mechanism)
hemothorax(blood in the pleural space; J94.2 nontraumatic, S27.1XXA traumatic; common post-surgical or trauma complication)
hemarthrosis(blood in a joint space; M25.00-M25.07 by site; seen in hemophilia and traumatic joint injuries)
hemoperitoneum(blood in the peritoneal cavity; K66.1; post-surgical or traumatic; high acuity inpatient diagnosis)
hemopneumothorax(combined blood and air in the pleural space; J94.2 / S27.2XXA; trauma-associated)
hemodialysis(extracorporeal blood purification for renal failure; Z99.2 dependence on renal dialysis; paired with N18.6 ESRD in urology inpatient accounts)
🔗 RELATED TERMS
-emia — the suffix counterpart to hemo-; where hemo- builds the front of a term identifying blood as subject, -emia closes the term naming a condition of the blood (e.g., anemia, uremia, leukemia); the two roots share the same Greek ancestor haima but occupy opposite structural positions in a word
-uria — suffix meaning “substance in the urine”; frequently paired with hemo- concepts in urology (e.g., hematuria bridges both roots — blood [hemo-] found in urine [-uria]); distinguish from hemoglobinuria, where free hemoglobin — not intact red cells — appears in urine
hemostasis — the physiological process of stopping blood flow through vasoconstriction, platelet aggregation, and coagulation; the clinical goal of hemo- procedures in surgical settings; disrupted in hemophilia and coagulopathies
hematopoiesis — normal blood cell formation occurring in the bone marrow; the productive/physiological counterpart to most pathological hemo- conditions; disrupted in aplastic anemia (D61.x) and leukemia (C91-C95.x)
hemolysis — destruction or breakdown of red blood cells, releasing hemoglobin into plasma; the core mechanism of hemolytic anemias (D55-D59.x); can be intravascular or extravascular
coagulation — the biochemical cascade converting fibrinogen to fibrin to form a blood clot; the mechanism underlying both hemostasis (therapeutic) and thrombosis (pathological); key to understanding hemo- bleeding disorders
hemophilia — X-linked hereditary bleeding disorder due to deficiency of coagulation factors; Hemophilia A (D66) — factor VIII deficiency; Hemophilia B (D67) — factor IX deficiency; the prototypical hemo- named disease
hemoglobinopathy — genetic disorder of hemoglobin structure or production; includes sickle cell disease (D57.x) and thalassemia (D56.x); major source of inpatient hematology admissions
disseminated intravascular coagulation (DIC) — systemic coagulation and fibrinolysis consuming clotting factors and platelets; D65; life-threatening hemo- emergency; MCC on inpatient accounts
thrombocytopenia — abnormal reduction in platelet count; D69.6 unspecified; often a secondary finding with hemo- bleeding presentations; distinguish etiology (immune vs. drug-induced vs. consumption)
anemia — the most clinically common blood condition; reduction in hemoglobin or red cell mass; shares the haima root with hemo-; coded D50-D64 by type and etiology
hematology — the medical specialty dedicated to the study and treatment of blood disorders; the clinical home of most hemo- diagnoses and procedures
complete blood count (CBC) — primary diagnostic laboratory tool for evaluating hemo- conditions; includes RBC, WBC, hemoglobin, hematocrit, platelets, and differential; CPT 85025
Cystourethroscopy with biopsy — urology; workup for hematuria source
⚠️ Coding Note: Hemo- terms in ICD-10-CM require site specificity in most categories — hemarthrosis (M25.0x) requires joint laterality, traumatic hematoma requires an S-code with episode of care (A/D/S), and hematuria (R31.x) must be coded to the most specific subtype documented (gross vs. microscopic vs. asymptomatic microscopic). In urology inpatient accounts, R31.9 (hematuria, unspecified) is a high-denial risk — query the provider when documentation distinguishes gross from microscopic or when cystoscopy findings specify the source; gross hematuria with clot retention is a distinct, higher-acuity presentation. Hemoptysis (R04.2) should never be the principal diagnosis when an underlying pulmonary condition (e.g., lung malignancy, bronchiectasis) is present and responsible for the admission — sequence the underlying condition first per ICD-10-CM convention. For DIC (D65), this is an MCC and should always trigger a query when documentation includes “consumptive coagulopathy,” “fibrinolysis,” or “clotting factor depletion” without an explicit DIC diagnosis. Postprocedural hematoma codes (T81.x) require a 7th character for episode of care and must be linked to the causative procedure — undercoding as M79.81 (nontraumatic soft tissue hematoma) is common and misrepresents the encounter.
Crystal's Coder Hub